[Federal Register: November 29, 2006 (Volume 71, Number 229)]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2006-26274]
Medical Review Board Meeting
AGENCY: Federal Motor Carrier Safety Administration (FMCSA).
ACTION: Notice of Meeting.
SUMMARY: FMCSA announces the next public meeting of its Medical Review
Board (MRB). The MRB members will continue deliberations about current
FMCSA medical standards, as well as consider recommendations for new
science-based standards and guidelines to ensure that the physical
condition of drivers is adequate to enable them to safely operate
commercial motor vehicles (CMVs) in interstate commerce. In accordance
with the Federal Advisory Committee Act (FACA), the meeting is open to
DATES: The MRB meeting will be held from 9 a.m. to 12:30 p.m. on
January 10, 2007.
ADDRESSES: The meeting will take place at the U.S. Department of
Transportation, 400 Seventh Street, SW., Nassif Building, Room 2230,
Washington, DC 20590-0001. The public must enter through the Southwest
Visitor Entrance and comply with building security procedures,
including provision of appropriate identification prior to being
accompanied by a Federal employee to the meeting rooms. You may submit
comments identified by DOT Docket Management System (DMS) Docket Number
FMCSA-2006-26274 using any of the following methods:
- Web site: http://dmses.dot.gov/submit. Follow the
instructions for submitting comments on the DOT electronic docket site.
- Fax: 1-202-493-2251.
- Mail: Docket Management Facility; U.S. Department of
Transportation, 400 Seventh Street, SW., Nassif Building, Room PL-401,
Washington, DC 20590-0001.
- Hand Delivery: Room PL-401 on the plaza level of the
Nassif Building, 400 Seventh Street, S.W., Washington, DC, between 9
a.m. and 5 p.m., Monday through Friday, except Federal holidays.
- Federal eRulemaking Portal: Go to http://www.regulations.gov.
Follow the online instructions for submitting comments.
Instructions: All submissions must include the Agency name and
docket number for this Notice. Note that all comments received will be
posted without change to http://dms.dot.gov including any personal
information provided. Please see the Privacy Act heading for further
Docket: For access to the docket to read background documents or
comments received, go to http://dms.dot.gov at any time or Room PL-401
on the plaza level of the Nassif Building, 400 Seventh Street, SW.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The DMS is available 24 hours each day, 365
days each year. If you want acknowledgment that we received your
comments, please include a self-addressed, stamped envelope or postcard
or print the acknowledgement page that appears after submitting
Privacy Act: Anyone may search the electronic form of all comments
received into any of our dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, etc.).
You may review the U.S. Department of Transportation's complete Privacy
Act Statement in the Federal Register published on April 11, 2000 (65
FR [[Page 69180]] 19477; Apr. 11, 2000). This information is also available at http://dms.dot.gov.
FOR FURTHER INFORMATION CONTACT: Dr. Mary D. Gunnels, Chief, Physical
Qualifications Division, 202-366-4001, FMCSA, Department of
Transportation, 400 Seventh Street, SW., Washington, DC 20590-0001.
Office hours are from 8:30 a.m. to 5 p.m. Monday through Friday, except
INFORMATION ON SERVICES FOR INDIVIDUALS WITH DISABILITIES: For
information on facilities or services for individuals with disabilities
or to request special assistance at the meeting, contact Kaye Kirby at
SUPPLEMENTARY INFORMATION: The preliminary agenda for the meeting
0900-0905 Call to Order, Agenda Review.
0905-0920 Medical Review Board (MRB) Actions.
0920-0945 Schedule II Medications.
0945-1015 Medications Expert Panel Recommendations.
1015-1045 MRB questions on Schedule II Medications.
1045-1145 Deliberations on Evidence Report & Panel Comments.
1145-1230 Public Comment Period.
*Breaks will be announced on meeting day and may be adjusted
according to schedule changes, other meeting requirements.
The U.S. Secretary of Transportation announced on March 7, 2006,
the five medical experts who serve on FMCSA's Medical Review Board
(MRB). Section 4116 of the Safe, Accountable, Flexible, Efficient
Transportation Equity Act: A Legacy for Users (SAFETEA-LU, Pub. L. 109-
59) requires the Secretary of Transportation with the advice of the MRB
to "establish, review, and revise medical standards for operators of
Commercial Motor Vehicles (CMVs) that will ensure that the physical
condition of operators is adequate to enable them operate the vehicles
safely." FMCSA is planning updates to the physical qualification
regulations of CMV drivers, and the MRB will provide the necessary
science-based guidance to establish realistic and responsible medical
The MRB operates in accordance with the Federal Advisory Committee
Act (FACA) as announced in the Federal Register (70 FR 57642, October
3, 2005). The MRB is charged initially with the review of all current
FMCSA medical standards (49 CFR 391.41), as well as proposing new
science-based standards and guidelines to ensure that drivers operating
CMVs in interstate commerce, as defined in CFR 390.5, are physically
capable of doing so.
Attendance is open to all interested parties, including the general
public, medical professionals, motor carriers, drivers and
representatives of associations. Written comments for this MRB meeting
are being accepted and will be accepted until January 25, 2007. Written
comments should include the docket number that is listed in the
ADDRESSES section. During the meeting, public oral comments are
accepted for 45 minutes (11:45 a.m. to 12:30 p.m.). Individual comments
may be limited depending on the number of persons who wish to comment.
Oral comments will be accepted on a first come, first serve basis as
requestors register at the meeting. The comments must directly address
relevant medical and scientific issues on the MRB meeting agenda. For
more information, please view the following Web site:
Issued on: November 22, 2006.
Pamela M. Pelcovits,
Office Director, Policy, Plans, and Regulations.
[FR Doc. E6-20247 Filed 11-28-06; 8:45 am]
BILLING CODE 4910-EX-P